UPTRAVI (selexipag) tablets | 合法藥品大搜索

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries ... Read More

UPTRAVI is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs. Read More

What is Uptravi and what is it used for? Read More

Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II–III, ... Read More

Uptravi. 成分 selexipag. 建議者. 愛可泰隆醫藥科技有限公司. 藥品許可證持有商. 愛可泰隆醫藥科技有限公司. 含量規格劑型. Selexipag film-coated tablets 200 mcg, ... Read More

UPTRAVI® (selexipag) is indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of ... Read More

UPTRAVI is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. UPTRAVI can ... Read More

Uptravi is indicated for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II–III, ... Read More

UPTRAVI® is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to. Read More